Literature DB >> 11162471

Structure elucidation of sphingolipids from the mycopathogen Sporothrix schenckii: identification of novel glycosylinositol phosphorylceramides with core manalpha1-->6Ins linkage.

M S Toledo1, S B Levery, J Glushka, A H Straus, H K Takahashi.   

Abstract

Acidic glycosphingolipid components were extracted from the mycelium form of the thermally dimorphic mycopathogen Sporothrix schenckii. Two fractions from the mycelium form (Ss-M1 and Ss-M2), having the highest Rf values on HPTLC analysis, were isolated and their structures elucidated by 1- and 2-D 13C- and 1H-nuclear magnetic resonance spectroscopy, and electrospray ionization mass spectrometry with lithium adduction of molecular ions. The structures of Ss-M1 and Ss-M2 were determined to be Manalpha1-->Ins1-P-1Cer and Manalpha1--> 3Manalpha1-->Ins1-P-1Cer, respectively (where Ins = myo-inositol, P = phosphodiester). The Manalpha1-->6Ins motif is found normally in diacylglycerol-based glycophosphatidylinositols of Mycobacteria, but this is the first unambiguous identification of the same linkage making up the core structure of fungal glycosylinositol phosphorylceramides (GIPCs). These results are discussed in relation to the structures of GIPCs of other mycopathogens, including Histoplasma capsulatum and Paracoccidioides brasiliensis. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11162471     DOI: 10.1006/bbrc.2000.4091

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Reactivity of MEST-1 (antigalactofuranose) with Trypanosoma cruzi glycosylinositol phosphorylceramides (GIPCs): immunolocalization of GIPCs in acidic vesicles of epimastigotes.

Authors:  E Suzuki; R A Mortara; H K Takahashi; A H Straus
Journal:  Clin Diagn Lab Immunol       Date:  2001-09

Review 2.  Role of sphingolipids in microbial pathogenesis.

Authors:  Lena J Heung; Chiara Luberto; Maurizio Del Poeta
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

Review 3.  Biosynthesis and immunogenicity of glucosylceramide in Cryptococcus neoformans and other human pathogens.

Authors:  Ryan Rhome; Travis McQuiston; Talar Kechichian; Alicja Bielawska; Mirko Hennig; Monica Drago; Giulia Morace; Chiara Luberto; Maurizio Del Poeta
Journal:  Eukaryot Cell       Date:  2007-08-10

4.  Glucosylceramide synthase is an essential regulator of pathogenicity of Cryptococcus neoformans.

Authors:  Philipp C Rittershaus; Talar B Kechichian; Jeremy C Allegood; Alfred H Merrill; Mirko Hennig; Chiara Luberto; Maurizio Del Poeta
Journal:  J Clin Invest       Date:  2006-06       Impact factor: 14.808

5.  Effect of anti-glycosphingolipid monoclonal antibodies in pathogenic fungal growth and differentiation. Characterization of monoclonal antibody MEST-3 directed to Manpalpha1-->3Manpalpha1-->2IPC.

Authors:  Marcos S Toledo; Loriane Tagliari; Erika Suzuki; Claudinei M Silva; Anita H Straus; Helio K Takahashi
Journal:  BMC Microbiol       Date:  2010-02-15       Impact factor: 3.605

6.  Characterization of inositol phosphorylceramides from Leishmania major by tandem mass spectrometry with electrospray ionization.

Authors:  Fong-Fu Hsu; John Turk; Kai Zhang; Stephen M Beverley
Journal:  J Am Soc Mass Spectrom       Date:  2007-06-02       Impact factor: 3.109

7.  Structural elucidation of novel phosphocholine-containing glycosylinositol-phosphoceramides in filamentous fungi and their induction of cell death of cultured rice cells.

Authors:  Kazuhiro Aoki; Ryosuke Uchiyama; Saki Itonori; Mutsumi Sugita; Fang-Sik Che; Akira Isogai; Noriyasu Hada; Junko Hada; Tadahiro Takeda; Hidehiko Kumagai; Kenji Yamamoto
Journal:  Biochem J       Date:  2004-03-01       Impact factor: 3.857

Review 8.  Biological Roles Played by Sphingolipids in Dimorphic and Filamentous Fungi.

Authors:  Caroline Mota Fernandes; Gustavo H Goldman; Maurizio Del Poeta
Journal:  mBio       Date:  2018-05-15       Impact factor: 7.867

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.